09:51 AM EST - WELL Health Technologies Corp. : Announced its interim consolidated financial results for the quarter ended September 30, 2025. WELL achieved record quarterly revenues of $364.6 million in Q3-2025, an increase of 56% compared to Q3-2024 driven by organic growth and acquisitions. WELL achieved record Adjusted EBITDA of $59.9 million in Q3-2025, an increase of 296% compared to $15.1 million in Q3-2024, representing Adjusted EBITDA margin of 16.4%. WELL Health Technologies Corp.
shares T.WELL are trading up $0.03 at $4.93.
